These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22803789)

  • 1. Clozapine for the treatment of schizophrenia.
    Fakra E; Azorin JM
    Expert Opin Pharmacother; 2012 Sep; 13(13):1923-35. PubMed ID: 22803789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of antipsychotic drugs: focus on therapeutic and adverse effects.
    Werner FM; Coveñas R
    Expert Opin Drug Saf; 2014 Aug; 13(8):1031-42. PubMed ID: 24975932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicide in schizophrenia: risk factors and clozapine treatment.
    Meltzer HY
    J Clin Psychiatry; 1998; 59 Suppl 3():15-20. PubMed ID: 9541333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia: The drug deadlock.
    Abbott A
    Nature; 2010 Nov; 468(7321):158-9. PubMed ID: 21068804
    [No Abstract]   [Full Text] [Related]  

  • 5. New vs. old antipsychotics: the Texas experience.
    Reid WH
    J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leponex, 10 years after -- a clinical review].
    Llorca PM; Pere JJ
    Encephale; 2004; 30(5):474-91. PubMed ID: 15627052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of atypical antipsychotics in chronic schizophrenia.
    Amin S
    Hosp Med; 1999 Jun; 60(6):410-3. PubMed ID: 10492711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study.
    Shiloh R; Zemishlany Z; Aizenberg D; Radwan M; Schwartz B; Dorfman-Etrog P; Modai I; Khaikin M; Weizman A
    Br J Psychiatry; 1997 Dec; 171():569-73. PubMed ID: 9519099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine treatment of schizophrenia.
    Pickar D; Hsiao JK
    JAMA; 1995 Sep; 274(12):981-3. PubMed ID: 7674530
    [No Abstract]   [Full Text] [Related]  

  • 11. Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial.
    Meltzer HY
    J Clin Psychiatry; 1999; 60 Suppl 12():47-50. PubMed ID: 10372612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P; Tallerico T
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Business Case for Expanded Clozapine Utilization.
    Gören JL; Rose AJ; Smith EG; Ney JP
    Psychiatr Serv; 2016 Nov; 67(11):1197-1205. PubMed ID: 27301766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
    Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
    Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK.
    Duggan A; Warner J; Knapp M; Kerwin R
    Br J Psychiatry; 2003 Jun; 182():505-8. PubMed ID: 12777341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
    Leucht S
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S15-20. PubMed ID: 14972080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.
    Honer WG; Procyshyn RM; Chen EY; MacEwan GW; Barr AM
    J Psychiatry Neurosci; 2009 Nov; 34(6):433-42. PubMed ID: 19949719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine for refractory schizophrenia: the Illinois experience.
    Buckman RW; Malan RD
    J Clin Psychiatry; 1999; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist.
    Nasrallah HA; Fedora R; Morton R
    Schizophr Res; 2019 Jun; 208():217-220. PubMed ID: 30837203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.